2015 Pediatric RX, Module 2: Respiratory Drugs

Introduction:

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 1.0 is pharmacology content.


IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright 2015 © by National Association of Pediatric Nurse Practitioners (NAPNAP)

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  1. Participants will have up-to-date information pharmacological management of common respiratory illnesses in children.
  2. Participants will understand the safety and efficacy of respiratory medications in children.
Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
10/01/2015
Course expires: 
09/30/2017
Cost:
$20.00

Teri Moser Woo, PhD, CPNP, CNL, FAANP, Associate Dean for Graduate Nursing Programs, Pacific Lutheran University, Tacoma, Wash.; Woodcreek Pediatrics, Puyallup, Wash.

 

FACULTY DISCLOSURES

Dr. Moser Woo has no financial relationships with any commercial entities to disclose, and will not discuss off label use and/or investigational use of individual drugs in this presentation.

Available Credit

  • 1.00 Contact hours

Price

Cost:
$20.00
Please login or register to take this course.